APTIMA

Device Gen-Probe, Inc.
Total Payments
$8.9M
Transactions
31,773
Doctors
21,148
Companies
6

Payment Trends by Year

Year Amount Transactions Doctors
2024 $1.7M 12,408 10,003
2023 $6.6M 8,996 7,020
2022 $319,123 6,226 5,148
2021 $172,237 4,099 3,580
2020 $1,583 14 12
2019 $4,567 4 3
2018 $3,319 12 12
2017 $1,211 14 14

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $6.5M 281 73.1%
Consulting Fee $1.3M 241 14.9%
Food and Beverage $800,003 30,646 9.0%
Travel and Lodging $223,512 586 2.5%
Honoraria $45,542 18 0.5%
Compensation for serving as faculty or as a speaker for a medical education program $1,200 1 0.0%

Payments by Type

Research
$6.5M
281 transactions
General
$2.4M
31,492 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
A10940-SC2/FluP-CSP-02 Gen-Probe, Inc. $4.8M 0
Year 3: Surveillance for Mycoplasma genitalium in US Sexually Transmitted Disease (STD) Clinics Gen-Probe, Inc. $695,716 0
655-A10940-001 Gen-Probe, Inc. $299,086 0
670-P10936-001 Gen-Probe, Inc. $195,404 0
A10960-SC2P-CSP-01 / A10960-SC2P-CSP-02 Gen-Probe, Inc. $147,509 0
655-A10960-001 Gen-Probe, Inc. $109,553 0
The association of Mycoplasma genitalium and adverse perinatal outcomes in high-risk pregnant women Gen-Probe, Inc. $83,347 0
Evaluation of the Aptima CMV Quant Assay in Plasma and Non-plasma samples Gen-Probe, Inc. $75,000 0
TTIMS, HIV RNA in whole blood compared to plasma as reservoir parameter, EQAPOL, Replicate Aptima HIV assay testing, Biomarkers predicting time to viral rebound, Gen-Probe, Inc. $36,309 0
Validation of Hologic-Developed Analyte Specific Reagents (ASR) for Detection of Genetic Markers of Macrolide Resistance in Mycoplasma genitalium Gen-Probe, Inc. $31,053 0
Year 2: Surveillance for Mycoplasma genitalium in US Sexually Transmitted Disease (STD) Clinics Gen-Probe, Inc. $19,004 0
TTIMS - Transfusion Transmissible Infection Monitoring System, HIV RNA in whole blood compared to plasma as reservoir parameter, EQAPOL, Replicate Aptima HIV assay testing, Biomarkers predicting time to viral rebound, Gen-Probe, Inc. $7,500 0
A10810-ATVPS-CSP Gen-Probe, Inc. $1,800 0

Top Doctors Receiving Payments for APTIMA — Page 846

Doctor Specialty Location Total Records
Shakeilah Burns Family Canton, OH $11.30 1
Yuhan Lee Family Medicine Alliance, OH $11.27 1
, CNP Nurse Practitioner Alliance, OH $11.27 1
Morgan White West Chester, OH $11.27 1
, CNP Women's Health Kent, OH $11.27 1
, PA-C Medical Alliance, OH $11.27 1
, MD Internal Medicine Glendale, CA $11.24 1
, D.O Obstetrics & Gynecology Trenton, MI $11.24 1
, D.O Obstetrics & Gynecology Trenton, MI $11.24 1
, D.O Obstetrics & Gynecology Fort Payne, AL $11.17 1
, M.D Pediatrics Fort Payne, AL $11.17 1
, CRNP Family Fort Payne, AL $11.16 1
, CRNP Family Fort Payne, AL $11.16 1
, M.D Obstetrics & Gynecology Fort Payne, AL $11.16 1
, D.O Family Medicine Post Falls, ID $11.15 1
, M.D Internal Medicine Orange, CA $11.10 1
, MD Internal Medicine Draper, UT $11.10 1
, NP Adult Health Orange, CA $11.10 1
, MD Obstetrics & Gynecology Cincinnati, OH $11.00 1
, MD Family Medicine Roan Mountain, TN $10.94 1
, M.D Gynecology Knoxville, TN $10.93 1
, MD Obstetrics & Gynecology Ft Wright, KY $8.39 1
, MD Gynecology Liberty Township, OH $8.39 1
, MD Obstetrics & Gynecology Orchard Lake, MI $7.71 1

About APTIMA

APTIMA is a device associated with $8.9M in payments to 21,148 healthcare providers, recorded across 31,773 transactions in the CMS Open Payments database. The primary manufacturer is Gen-Probe, Inc..

Payment data is available from 2017 to 2024. In 2024, $1.7M was paid across 12,408 transactions to 10,003 doctors.

The most common payment nature for APTIMA is "Unspecified" ($6.5M, 73.1% of total).

APTIMA is associated with 13 research studies, including "A10940-SC2/FluP-CSP-02" ($4.8M).